vs
GoodRx Holdings, Inc.（GDRX）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是GoodRx Holdings, Inc.的1.1倍（$212.2M vs $194.8M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 2.8%，领先16.0%），LiveRamp Holdings, Inc.同比增速更快（8.6% vs -1.9%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs -0.8%）
GoodRx是一家美国医疗健康企业，运营着远程医疗平台以及可免费使用的网站与移动应用，服务覆盖美国超75000家药店，可为用户追踪处方药价格、提供药品优惠折扣券，还支持用户在线问诊，获取部分品类药物的处方。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
GDRX vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.1倍
$194.8M
营收增速更快
RAMP
高出10.5%
-1.9%
净利率更高
RAMP
高出16.0%
2.8%
两年增速更快
RAMP
近两年复合增速
-0.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $194.8M | $212.2M |
| 净利润 | $5.4M | $39.9M |
| 毛利率 | — | 71.9% |
| 营业利润率 | 11.6% | 18.6% |
| 净利率 | 2.8% | 18.8% |
| 营收同比 | -1.9% | 8.6% |
| 净利润同比 | -19.5% | 255.7% |
| 每股收益（稀释后） | $0.02 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDRXRAMP
| Q4 25 | $194.8M | $212.2M | ||
| Q3 25 | $196.0M | $199.8M | ||
| Q2 25 | $203.1M | $194.8M | ||
| Q1 25 | $203.0M | $188.7M | ||
| Q4 24 | $198.6M | $195.4M | ||
| Q3 24 | $195.3M | $185.5M | ||
| Q2 24 | $200.6M | $176.0M | ||
| Q1 24 | $197.9M | $171.9M |
净利润GDRXRAMP
| Q4 25 | $5.4M | $39.9M | ||
| Q3 25 | $1.1M | $27.4M | ||
| Q2 25 | $12.8M | $7.7M | ||
| Q1 25 | $11.1M | $-6.3M | ||
| Q4 24 | $6.7M | $11.2M | ||
| Q3 24 | $4.0M | $1.7M | ||
| Q2 24 | $6.7M | $-7.5M | ||
| Q1 24 | $-1.0M | $-5.4M |
毛利率GDRXRAMP
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.1% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率GDRXRAMP
| Q4 25 | 11.6% | 18.6% | ||
| Q3 25 | 7.5% | 10.7% | ||
| Q2 25 | 13.2% | 3.7% | ||
| Q1 25 | 11.5% | -6.1% | ||
| Q4 24 | 9.2% | 7.5% | ||
| Q3 24 | 10.5% | 4.0% | ||
| Q2 24 | 9.9% | -3.0% | ||
| Q1 24 | 3.7% | -8.3% |
净利率GDRXRAMP
| Q4 25 | 2.8% | 18.8% | ||
| Q3 25 | 0.6% | 13.7% | ||
| Q2 25 | 6.3% | 4.0% | ||
| Q1 25 | 5.4% | -3.3% | ||
| Q4 24 | 3.4% | 5.7% | ||
| Q3 24 | 2.0% | 0.9% | ||
| Q2 24 | 3.3% | -4.3% | ||
| Q1 24 | -0.5% | -3.1% |
每股收益（稀释后）GDRXRAMP
| Q4 25 | $0.02 | $0.62 | ||
| Q3 25 | $0.00 | $0.42 | ||
| Q2 25 | $0.04 | $0.12 | ||
| Q1 25 | $0.03 | $-0.10 | ||
| Q4 24 | $0.01 | $0.17 | ||
| Q3 24 | $0.01 | $0.03 | ||
| Q2 24 | $0.02 | $-0.11 | ||
| Q1 24 | $0.00 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $261.8M | $403.4M |
| 总债务越低越好 | $495.0M | — |
| 股东权益账面价值 | $616.3M | $962.3M |
| 总资产 | $1.4B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
现金及短期投资GDRXRAMP
| Q4 25 | $261.8M | $403.4M | ||
| Q3 25 | $273.5M | $376.9M | ||
| Q2 25 | $281.3M | $371.1M | ||
| Q1 25 | $301.0M | $420.8M | ||
| Q4 24 | $448.3M | $384.3M | ||
| Q3 24 | $423.8M | $348.4M | ||
| Q2 24 | $524.9M | $342.7M | ||
| Q1 24 | $533.3M | $368.9M |
总债务GDRXRAMP
| Q4 25 | $495.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $500.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GDRXRAMP
| Q4 25 | $616.3M | $962.3M | ||
| Q3 25 | $600.7M | $943.8M | ||
| Q2 25 | $643.0M | $947.8M | ||
| Q1 25 | $654.3M | $948.9M | ||
| Q4 24 | $724.7M | $957.7M | ||
| Q3 24 | $696.4M | $932.1M | ||
| Q2 24 | $669.4M | $951.9M | ||
| Q1 24 | $631.1M | $949.1M |
总资产GDRXRAMP
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.5B | $1.2B |
负债/权益比GDRXRAMP
| Q4 25 | 0.80× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | — |
| 自由现金流经营现金流 - 资本支出 | $31.6M | — |
| 自由现金流率自由现金流/营收 | 16.2% | — |
| 资本支出强度资本支出/营收 | 0.6% | 0.1% |
| 现金转化率经营现金流/净利润 | 6.06× | — |
| 过去12个月自由现金流最近4个季度 | $164.4M | — |
8季度趋势，按日历期对齐
经营现金流GDRXRAMP
| Q4 25 | $32.9M | — | ||
| Q3 25 | $76.0M | $57.4M | ||
| Q2 25 | $49.6M | $-15.8M | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $44.7M | $45.1M | ||
| Q3 24 | $86.9M | $55.6M | ||
| Q2 24 | $9.7M | $-9.3M | ||
| Q1 24 | $42.6M | — |
自由现金流GDRXRAMP
| Q4 25 | $31.6M | — | ||
| Q3 25 | $74.3M | $56.8M | ||
| Q2 25 | $49.2M | $-16.2M | ||
| Q1 25 | $9.3M | — | ||
| Q4 24 | $44.6M | $44.8M | ||
| Q3 24 | $86.5M | $55.4M | ||
| Q2 24 | $9.4M | $-9.6M | ||
| Q1 24 | $42.2M | — |
自由现金流率GDRXRAMP
| Q4 25 | 16.2% | — | ||
| Q3 25 | 37.9% | 28.4% | ||
| Q2 25 | 24.2% | -8.3% | ||
| Q1 25 | 4.6% | — | ||
| Q4 24 | 22.4% | 22.9% | ||
| Q3 24 | 44.3% | 29.8% | ||
| Q2 24 | 4.7% | -5.4% | ||
| Q1 24 | 21.3% | — |
资本支出强度GDRXRAMP
| Q4 25 | 0.6% | 0.1% | ||
| Q3 25 | 0.9% | 0.3% | ||
| Q2 25 | 0.2% | 0.2% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 0.2% | 0.1% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.2% | 1.0% |
现金转化率GDRXRAMP
| Q4 25 | 6.06× | — | ||
| Q3 25 | 67.94× | 2.09× | ||
| Q2 25 | 3.86× | -2.04× | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 6.64× | 4.02× | ||
| Q3 24 | 21.91× | 32.10× | ||
| Q2 24 | 1.45× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDRX
| Prescription Transactions Revenue | $124.7M | 64% |
| Other | $44.4M | 23% |
| Subscription Revenue | $21.6M | 11% |
| Other Revenue | $4.1M | 2% |
RAMP
暂无分部数据
